In late July, we noted, “Keep an eye on Elevance Health (ELV). Over the last few days, the stock gapped from about $340 to a low of about $274.40. That was after the health insurer cut its guidance. However, it appears most of that negativity has been priced into...
Every time Vertex Pharmaceuticals (VTKX) becomes as technically oversold as it is now, it bounces back strong. In fact, if you pull up a one-year chart of VRTX, with RSI, MACD, and Williams’ %R, you’ll see that when these indicators all drop into oversold territory,...
On July 16, we noted, “Apple looks interesting. Last trading at $210.40, we’d like to see the tech giant break above triple top resistance with a near-term bearish gap refill at around $220. Helping, analysts at Jefferies just raised their price target on Apple to...
Just a few weeks ago, we said, “After a brief pullback, shares of Advanced Micro Devices (AMD) are just starting to pivot higher again. Last trading at $157.10, we’d like to see the stock test $175, near-term. Helping, AMD Executive Vice President and Chief...
by Ian Cooper The artificial intelligence boom shows no signs of cooling. Instead, it’s still heating up – with companies spending billions in capex on AI opportunities. In fact, Alphabet just announced it will boost its capital-expenditure forecast for the year to...
President Trump just said he might reclassify cannabis as having a lower danger level. On that news, shares of Canopy Growth (CGC) jumped more than 26%. Trulieve (TRUL) jumped 36%. And Tilray (TLRY) closed the day up about 42%. While impressive, all could see higher...
Keep an eye on lesser-known obesity drug stocks, like Viking Therapeutics (VKTX). Just days ago, Eli Lilly reported that its experimental weight loss pill helped patients lose about 11% of their body weight. However, that landed at the lower end of Wall Street’s...
After gapping from about $120 to $86.67, UPS (UPS) now sits at 2020 lows. All thanks to recent earnings and pulled guidance. In its most recent quarter, UPS’ EPS of $1.55 missed by two cents. Revenue of $21.2 billion, down 2.8% year over year, did beat by $350...
Ahead of the 2025 NFL season, gambling stocks, like DraftKings (SYM: DKNG) are exploding. Just as it did in 2024. A year ago, the American Gaming Association said Americans were expected to spend about $35 billion on NFL games this year. That’s up from the...
Keep an eye on Halozyme Therapeutics (HALO). Last trading at $60.81, we’d like to see it refill its bearish gap at around $64 initially. Helping, analysts at Morgan Stanley just upgraded HALO to overweight with a price target of $75. The firm believes the...